Yazhou Cui

Yazhou Cui

Auto-generated profile, based on publicly available information

Yazhou Cui

Key Laboratory for Biotech Drugs of the Ministry of Health, Shandong Medical Biotechnological Center, Shandong Academy of Medical Sciences

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2015 in FEBS Letters
Verified
Journal Article
Open access
PDF file
YCYazhou Cui
Yazhou Cui
JLJing Luan
Jing Luan
HLHaiying Li
Haiying Li
XZXiaoyan Zhou
Xiaoyan Zhou
JHJinxiang Han
Jinxiang Han
Mineralizing osteoblasts (MOBs) can release exosomes, although the functional significance remains unclear. In the present study, we demonstrate that exosomes derived from mineralizing pre‐osteoblast MC3T3‐E1 cells can promote bone marrow stromal cell (ST2) differentiation to osteoblasts. We reveal that MOB‐derived exosomes significantly influence miRNA profiles in recipient ST2 cells, and these changes tend to activate the Wnt signaling pathway by inhibiting Axin1 expression and increasing β‐catenin expression. We also suggest that MOB derived‐exosomes partly induce the variation in miRNA expression in recipient ST2 cells by exosomal miRNA transfer. These findings suggest an exosome‐mediated mode of cell‐to‐cell communication in the osteogenic microenvironment, and also indicate the potential of MOB exosomes in bone tissue engineering.

16 August 2008 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MTMei Tian
Mei Tian
YCYa-Zhou Cui
Ya-Zhou Cui
GSGuan-Hua Song
Guan-Hua Song
MZMei-Juan Zong
Mei-Juan Zong
JYJianding Ye
Jianding Ye
JHJin-Xiang Han
Jin-Xiang Han
Background: There is an urgent need to discover more sensitive and specific biomarkers to improve early diagnosis and screen high-risk patients for pancreatic ductal adenocarcinoma (PDAC). Pancreatic juice is an ideal specimen for PDAC biomarkers discovery, because it is an exceptionally rich source of proteins released from pancreatic cancer cells. Methods: To identify novel potential biomarkers for PDAC from pancreatic juice, we carried out difference gel electrophoresis (DIGE) and tandem mass spectrometry (MS/MS) to compare the pancreatic juice profiling from 9 PDAC patients and 9 cancer-free controls. Of the identified differently expressed proteins, three up-regulated proteins in pancreatic cancer juice, matrix metalloproteinase-9 (MMP-9), oncogene DJ1 (DJ-1) and alpha-1B-glycoprotein precursor (A1BG), were selected for validation by Western blot and immunohistochemistry. Serum MMP-9 levels were also detected by enzyme linked immunosorbent assay (ELISA). Results: Fourteen proteins were up-regulated and ten proteins were down-regulated in cancerous pancreatic juice compared with cancer-free controls. Increased MMP-9, DJ-1 and A1BG expression in cancerous pancreatic juice were confirmed by Western blot. Immunohistochemical study showed MMP-9, DJ-1 and A1BG positively expressed in 82.4%, 72.5% and 86.3% of pancreatic cancer tissues, significantly higher than that in normal pancreas tissues. Up-regulation of DJ-1 was associated with better differentiation (p < 0.05). Serum MMP-9 levels were significantly higher in PDAC (255.14 ng/ml) than those in chronic pancreatitis (210.22 ng/ml, p = 0.009) and healthy control (203.77 ng/ml, p = 0.027). Conclusion: The present proteome analysis revealed MMP-9, DJ-1 and A1BG proteins as elevated in pancreatic juice from PDAC, which suggest their further utility in PDAC diagnosis and screening. This is the first time A1BG was identified as a potential biomarker in pancreatic cancer associated samples. The measurement of serum MMP-9 might be clinically useful for PDAC diagnosis.

1 January 2015 in Intractable & Rare Diseases Research
Verified
Journal Article
Closed access
PDF file
CWChao Wang
Chao Wang
YCYazhou Cui
Yazhou Cui
YLYan Li
Yan Li
XLXiao Liu
Xiao Liu
JHJinxiang Han
Jinxiang Han
Epidemiological information of hereditary spherocytosis in China is slight. This systematic review summarizes the number of cases of hereditary spherocytosis reported in China Biology Medicine disc from 1978 to 2013. In total, 2,043 cases were reported in the past 36 years. We describe its distribution from time and space. We also estimate the literature reported prevalence of hereditary spherocytosis by DisMod-II software, overall prevalence in China was estimated to be: 1.27 cases per 100,000 people in males and 1.49 cases per 100,000 people in females. All results suggest a stronger network of diagnosis and treatment including all levels of hospitals should be created to improve healthcare for hereditary spherocytosis and even other rare diseases in the future, meanwhile we can obtain more useful information for orphan drug designation purposes and make public health decisions regarding such diseases through the use of the burden of disease models.

1 January 2004 in Tumor Biology
Verified
Journal Article
Closed access
CYCui Yazhou
Cui Yazhou
SWShen Wenlv
Shen Wenlv
ZWZhang Weidong
Zhang Weidong
WLWu Licun
Wu Licun

28 January 2009 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
PDF file
HJHongjuan Jiang
Hongjuan Jiang
GGGuangju Guan
Guangju Guan
RZRui Zhang
Rui Zhang
GLGang Liu
Gang Liu
JCJing Cheng
Jing Cheng
YCYazhou Cui
Yazhou Cui

15 April 2009 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
XCXiaotian Chang
Xiaotian Chang
YCYazhou Cui
Yazhou Cui
MZMeijuan Zong
Meijuan Zong
YZYan Zhao
Yan Zhao
XYXinfeng Yan
Xinfeng Yan
JHJinxiang Han
Jinxiang Han
Objective. A proteomic approach was applied to discover novel rheumatoid arthritis (RA)-specific proteins by comparing the expression profiles of synovial membranes from patients with RA, osteoarthritis (OA), and ankylosing spondylitis (AS).